nAChRs are pentameric molecules formed from identical or homologous subunits to form homomeric and heteromeric assemblies. They play a critical role in the peripheral and central nervous systems to mediate neurotransmission by acetylcholine and, as such, are critical targets for understanding nicotine addiction and developing useful drugs for treating CNS disorders such as schizophrenia, Parkinson’s disease and disorders of dementias. The acetylcholine binding protein (AChBP) is a pentameric structural homologue of the extracellular ligand‐binding domain of nAChRs. Up until recently, this approach has yielded compounds that bind as would be predicted by a equivalent set of five sites in the pentameric molecule, a situation also seen with classical natural product agonists and antagonists binding to the AChBP. Very recently through our synthetic program, we have uncovered a set of new structures that exhibit cooperativity, where many show Hill slopes greater than 1.0 or considerably less than 1.0. The latter is not due to heterogeneity of the binding protein template, since AChBP has five identical sites as examined crystallographically and by conventional ligand binding. Through the structural analysis, we can delineate the structural features of the ligands inducing this new mode of association with the extracellular domain of the receptor. Our approach of finding a series of ~50 congeneric ligands where individual members can be distinguished by positive and negative cooperativity should shed new light on subunit interactions in this homopentamer. For example, cooperative interactions appear to link in a circumferential fashion around the perimeter of the extracellular domain and do not necessarily require a direct connection with the channel gate area to elicit subunit interactions. This unique feature of our series of ligands gives a high promise to develop medications with distinct pharmacological profiles.Grant Funding Source: TRDRP (21FT_0024); NIH (GM 18360)
Read full abstract